MYOMO, INC. (MYO) Q3 2025 10-Q Quarterly Report
Filed: Nov 10, 2025Period ending Sep 30, 2025
Health Care
Orthopedic, Prosthetic & Surgical Appliances & SuppliesSEC EDGAR MYOMO, INC. (MYO) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 10, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
MYOMO, INC. Q3 2025 10-Q Analysis
Risk Factors
- • New direct-to-consumer advertising risk triggered by social media algorithm change in Q1 2025 causing higher cost per pipeline add and lower lead generation
- • Material update to capital risk from $17.5M loan facility entered Nov 2025, replacing prior $7M facility, with covenants restricting operations and financial flexibility
- • Regulatory risk from ongoing Medicare pre-payment audits impacting 43 claims, with 8 claims currently under appeal as of 10-Q filing date
- • Near-term market risk from Medicare Advantage plans reducing MyoPro authorizations, lowering revenues from 24% to 18% of total quarterly revenue YoY
- • Financial liquidity risk: $12.6M cash Sept 30, 2025, with recent borrowings of $3M term loan and $1M line of credit, expected to fund operations for next 12 months
MYOMO, INC. Q3 2025 Quarterly FinancialsXBRL
Revenue
$10M
▲ +9.6% YoY▲ +4.5% QoQ
Net Income
-$4M
▼ -279.0% YoY▲ +20.9% QoQ
Gross Margin
63.8%
▼ -1159bp YoY▲ +114bp QoQ
Operating Margin
-34.9%
▼ -2446bp YoY▲ +1270bp QoQ
Net Margin
-36.3%
▼ -2580bp YoY▲ +1169bp QoQ
ROE
-25.0%
Total Assets
$34M
EPS (Diluted)
$-0.08
▼ -166.7% YoY▲ +33.3% QoQ
Operating Cash Flow
-$2M
▼ -22.4% YoY▲ +79.4% QoQ
Source: XBRL data from MYOMO, INC. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on MYOMO, INC.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.